These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 3926643)

  • 21. In vitro and in vivo anti-biofilm activity of pyran derivative against Staphylococcus aureus and Pseudomonas aeruginosa.
    Su S; Yin P; Li J; Chen G; Wang Y; Qu D; Li Z; Xue X; Luo X; Li M
    J Infect Public Health; 2020 May; 13(5):791-799. PubMed ID: 31813834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microbiology of airway disease in patients with cystic fibrosis.
    Gilligan PH
    Clin Microbiol Rev; 1991 Jan; 4(1):35-51. PubMed ID: 1900735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo antibacterial activity of S-3578, a new broad-spectrum cephalosporin: methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa experimental infection models.
    Tsuji M; Takema M; Miwa H; Shimada J; Kuwahara S
    Antimicrob Agents Chemother; 2003 Aug; 47(8):2507-12. PubMed ID: 12878512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of a cyclooxygenase inhibitor on the in vivo polymorphonuclear leukocyte migration to Pseudomonas aeruginosa peptide chemotactins.
    Fontán PA; Amura CR; Sordelli DO
    Agents Actions; 1993 Sep; 40(1-2):106-9. PubMed ID: 8147264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pulmonary Pathogens Adapt to Immune Signaling Metabolites in the Airway.
    Riquelme SA; Wong Fok Lung T; Prince A
    Front Immunol; 2020; 11():385. PubMed ID: 32231665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Colonization of CF patients' upper airways with S. aureus contributes more decisively to upper airway inflammation than P. aeruginosa.
    Janhsen WK; Arnold C; Hentschel J; Lehmann T; Pfister W; Baier M; Böer K; Hünniger K; Kurzai O; Hipler UC; Mainz JG
    Med Microbiol Immunol; 2016 Oct; 205(5):485-500. PubMed ID: 27377929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New approaches to Pseudomonas aeruginosa lower respiratory tract infections.
    Matsumoto K
    Verh K Acad Geneeskd Belg; 1995; 57(2):109-22. PubMed ID: 7571853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibiotic pressure compensates the biological cost associated with Pseudomonas aeruginosa hypermutable phenotypes in vitro and in a murine model of chronic airways infection.
    Alcalá-Franco B; Montanari S; Cigana C; Bertoni G; Oliver A; Bragonzi A
    J Antimicrob Chemother; 2012 Apr; 67(4):962-9. PubMed ID: 22294647
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1994)].
    Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kobayashi K; Satou K; Matsumiya H; Saito A; Terai T; Tanno Y; Nishioka K; Arakawa M; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Matsuda M; Tanimoto H; Nakata K; Nakamori Y; Kusano N
    Jpn J Antibiot; 1996 May; 49(5):419-55. PubMed ID: 8752860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1997)].
    Ikemoto H; Ito C; Yoshida T; Watanabe K; Mori T; Ohno I; Okada S; Igari J; Arakawa M; Igarashi K; Oguri T; Okada M; Ozaki K; Terai T; Aoki N; Inoue H; Nakadate T; Kitamura N; Sekine O; Suzuki Y; Ando M; Suga M; Sato K; Nakata K; Kusano N
    Jpn J Antibiot; 1999 May; 52(5):353-97. PubMed ID: 10480048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Characteristics of the increased resistance of mice to Pseudomonas aeruginosa caused by Staphylococcus aureus].
    Mathieu LG; deRepentigny J; Gadbois T
    Can J Microbiol; 1976 Dec; 22(12):1734-42. PubMed ID: 827329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction of elastase from Pseudomonas aeruginosa with polymorphonuclear leukocytes and serum.
    Pajdak E; Pituch-Noworolska A; Stankiewicz D
    Arch Immunol Ther Exp (Warsz); 1985; 33(4):499-505. PubMed ID: 3936453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibacterial Properties of Tebipenem Pivoxil Tablet, a New Oral Carbapenem Preparation against a Variety of Pathogenic Bacteria in Vitro and in Vivo.
    Yao Q; Wang J; Cui T; Yang Z; Su M; Zhao P; Yan H; Zhan Y; Yang H
    Molecules; 2016 Jan; 21(1):62. PubMed ID: 26751436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Innate lung defenses and compromised Pseudomonas aeruginosa clearance in the malnourished mouse model of respiratory infections in cystic fibrosis.
    Yu H; Nasr SZ; Deretic V
    Infect Immun; 2000 Apr; 68(4):2142-7. PubMed ID: 10722612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impaired lung defenses against Staphylococcus aureus in mice with hereditary deficiency of the fifth component of complement.
    Cerquetti MC; Sordelli DO; Ortegon RA; Bellanti JA
    Infect Immun; 1983 Sep; 41(3):1071-6. PubMed ID: 6350178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aerosolized Polymyxin B for Treatment of Respiratory Tract Infections: Determination of Pharmacokinetic-Pharmacodynamic Indices for Aerosolized Polymyxin B against Pseudomonas aeruginosa in a Mouse Lung Infection Model.
    Lin YW; Zhou Q; Onufrak NJ; Wirth V; Chen K; Wang J; Forrest A; Chan HK; Li J
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559256
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral immunization of mice with temperature-sensitive Pseudomonas aeruginosa enhances pulmonary clearance of the wild-type.
    Hooke AM; Cerquetti MC; Wan KS; Wang Z; Sordelli DO; Bellanti JA
    Vaccine; 1991 May; 9(5):294-6. PubMed ID: 1908162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic wound infections: the role of Pseudomonas aeruginosa and Staphylococcus aureus.
    Serra R; Grande R; Butrico L; Rossi A; Settimio UF; Caroleo B; Amato B; Gallelli L; de Franciscis S
    Expert Rev Anti Infect Ther; 2015 May; 13(5):605-13. PubMed ID: 25746414
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The reciprocal effect of the causative agents in a mixed infection in burn injury].
    Bel'skiĭ VV; Shatalova EV
    Zh Mikrobiol Epidemiol Immunobiol; 1999; (4):3-7. PubMed ID: 10852039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bacterial stimulation of epithelial G-CSF and GM-CSF expression promotes PMN survival in CF airways.
    Saba S; Soong G; Greenberg S; Prince A
    Am J Respir Cell Mol Biol; 2002 Nov; 27(5):561-7. PubMed ID: 12397015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.